Trial intelligence / Profile preview

PRT vs Non-PRT Platelets in Cardiac Surgery

NCT06535360Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
Sep 2020
Primary completion
May 2023
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 4 trial of Pathogen-reduced platelets in hemorrhage, sponsored by University of Maryland, Baltimore. Started Sep 2020; status: completed.

02

Drugs

Pathogen-reduced platelets
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT06535360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06535360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call